Hostname: page-component-745bb68f8f-hvd4g Total loading time: 0 Render date: 2025-02-11T07:22:05.088Z Has data issue: false hasContentIssue false
  • English
  • Français

P-1370 - Effectiveness of Transcranial Magnetic Stimulation in Treatment of Depressed Patients With Chronic Pain

Published online by Cambridge University Press:  15 April 2020

G. Musher ,
V. Bokarius  and
A.V. Bokarius
G. Musher
Affiliation:
Galaxy Medical Center, Los Angeles, Irvine, CA, USA
V. Bokarius
Affiliation:
Comprehensive Care Consultants, San Mateo, Irvine, CA, USA
A.V. Bokarius
Affiliation:
Medical School, University of California Irvine School of Medicine, Irvine, CA, USA

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Treatment of resistant depression is known to be a challenging task; especially in patients with comorbid chronic pain. Efficiency of Transcranial Magnetic Stimulation (TMS) was demonstrated in treatment of medication resistant Major Depressive Disorder.

Objectives

To evaluate the effectiveness of TMS in depressed patients with chronic pain in a naturalistic outpatient treatment setting.

Aims

To evaluate the significance of improvement in depressive symptoms in response to TMS course and to compare the response of two groups of patients: with changes in psychotropic medications during the TMS course and without changes.

A retrospective cohort study queried the database of patients with treatment resistant depression and comorbid chronic pain. The severity of depressive symptomatology was assessed with 21-item Hamilton Depression Rating Scale (HAM-D) before and after TMS. Patients were distributed to Group A (N = 53; with changes in psychotropic medications) and Group B (N = 21; without changes in psychotropic medications). Data were charted and analyzed by t-tests and percent change.

HAM-D percent changes between Groups A and B revealed a significant difference (p < 0.01). Based on Group B results, a population can expect at least 30% decrease in

HAM-D scores following TMS (p < 0.05). Conversely, according to Group A, 30% decrease cannot be expected (p < 0.05). Furthermore, Group B demonstrated greater percentage of patients with >50% decrease in HAM-D scores over Group A.

TMS is effective in decreasing symptoms of depression in patients with chronic pain.

TMS was more effective in patients who did not have changes in psychotropic medications during treatment.

Type
Abstract
Information
European Psychiatry , Volume 27 , Issue S1: Abstracts of the 20th European Congress of Psychiatry , 2012 , pp. 1
Copyright
Copyright © European Psychiatric Association 2012
Submit a response

Comments

No Comments have been published for this article.